BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Genetown

  Second Annual Consumer Genetics Conference – The Spotlight Shines On Boston June 2-4, 2010

  November 16, 2009

   · 

  1 min read
• Pharm Country

  Celgene Corporation to Present at the Lazard Capital Markets 6th Annual Healthcare Conference

  November 16, 2009

   · 

  1 min read
• King Pharmaceuticals®, Inc. to Present at Lazard Capital Markets Healthcare Conference

  November 16, 2009

   · 

  1 min read
• Drug Development

  Phase 1/2 Results for Aldagen, Inc.'s ALD-301 Critical Limb Ischemia Clinical Study Presented at American Heart Association

  November 16, 2009

   · 

  5 min read
• Vicor Technologies, Inc. Announces Filing of 10-Q on November 13, 2009

  November 16, 2009

   · 

  7 min read
• Pharm Country

  Eisai Inc.: LUSEDRA(TM) (fospropofol disodium) Injection CIV for Monitored Anesthesia Care (MAC) Sedation Now Available

  November 16, 2009

   · 

  3 min read
• Business

  Sunesis Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of 2009

  November 16, 2009

   · 

  15 min read
• Business

  CambridgeSoft Corporation Announces Investment by Health Evolution Partners and Goldman, Sachs & Co.

  November 16, 2009

   · 

  3 min read
• Business

  Skystar Bio-Pharmaceutical Announces Third Quarter 2009 Financial Results

  November 16, 2009

   · 

  18 min read
• Drug Development

  Myriad Pharmaceuticals, Inc. Confirms That MPC-3100, a Fully-Synthetic Hsp90 Inhibitor, is Orally-Bioavailable in Patients in Phase 1 Studies

  November 16, 2009

   · 

  1 min read